Loading...
Facioscapulohumeral dystrophy (FSHD) is considered the second most frequent adult-onset muscular dystrophy. Muscular ultrasound (MUS) has potential to assess disease progression. It can show abnormalities in tissue composition, architecture, and movement, allowing tracking of changes over time.
To assess muscle ultrasound as a biomarker in patients with FSHD, investigators recruited 22 patients. Patients underwent a clinical examination and quantitative and qualitative MUS at baseline and after 1 year of follow-up.
Both quantitative and qualitative MUS scores increased significantly. The clinical scores did not change during follow-up. Baseline muscle echogenicity and FSHD clinical scores were correlated.